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Context: Polycystic ovary syndrome (PCOS) is a common female endocrine disorder characterized
by phenotypes ranging from hyperandrogenism tometabolic disorders, more prevalent in people
of African/Caucasian and Asian ancestry. Because PCOS impairs fertility without diminishing in
prevalence, it was considered an evolutionary paradox. Genome-Wide Association Studies iden-
tified 17 single nucleotide polymorphisms (SNPs) associated with PCOS, with different allele fre-
quencies, ethnicity-related, in 11 susceptibility loci.
Objective: In this studywe analyze the PCOS phenotype-genotype relationship in silico, using SNPs
of representative genes for analysis of genetic clustering and distance, to evaluate the degree of
genetic similarity.
Data Source: 1000 Genomes, HapMap, and HumanGenomeDiversity Project databases were used
as source of allele frequencies of the SNPs, using data from male and female individuals grouped
according to their geographical ancestry.
Setting and Design: Genetic clustering was calculated from SNPs data by Bayesian inference. The
inferredancestryof individualswasmatchedwithPCOSphenotypedata, extracted fromaprevious
meta-analysis. The measure of genetic distance was plotted against the geographic distance be-
tween the populations.
Results: The individuals were assigned to five genetic clusters, matching with different world
regions (Kruskal-Wallis/Dunn’s post test; P .0001), and converging in twomain PCOS phenotypes
indifferentdegreesofaffinity. Theoverall geneticdistance increasedwith thegeographicdistance
among thepopulations (linear regression;R20.21;P .0001), in aphenotype-unrelatedmanner.
Conclusions: Phenotype-genotype correlations were demonstrated, suggesting that PCOS genetic
gradient results from genetic drift due to a serial founder effect occurred during ancient human
migrations.Theoverallprevalenceofthediseasesupports intralocussexualconflictasalternativetothe
natural selection of phenotypic traits in females. (J Clin Endocrinol Metab 99: E2412–E2420, 2014)
Polycystic ovary syndrome (PCOS) is themost commonendocrinopathy affecting 5–10% of women in re-
productive age worldwide. It is a familial, polygenic con-
dition associated with infertility, irregular menstrual
cycles, anovulation, hyperandrogenism, as well as nonre-
productive health problems depending on genetic back-
ground and affected by lifestyle (1–3).
PCOS phenotypic features
Even if the disease displays a wide variety of charac-
teristics, it is widely accepted that PCOS features decrease
within two main phenotypes. According to the 2003 Rot-
terdam criteria (4), the prevalent clinical symptoms define
the hyperandrogenic or metabolic phenotype (5–10). The
hyperandrogenic PCOS phenotype is defined mainly by
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hirsutism, androgenic alopecia, and relatively high andro-
gen levels, whereas the metabolic phenotype is character-
ized by metabolic syndrome, insulin resistance, increased
risk for type 2 diabetes, and high body mass index or
central obesity (5–10). It canbeapproximately established
that the metabolic phenotype is prevalent in Central
Asians and Americans whereas the hyperandrogenic phe-
notype is prevalent in the other world regions. However,
the wide spectrum of secondary disorders results in an
overlap of PCOS characteristics among human popula-
tions, reflecting the polygenic condition of the disease and
genetic admixture. Curiously, no clear differences in the
prevalence of the disease among different ethnic groups
has been identified so far (10–15).
Evolutionary origin of PCOS
Given that the disease impairs fertility without dimin-
ishing its high global prevalence, it was extensively dis-
cussed as an evolutionary paradox. Previous studies at-
tempted to explain how a genetic pattern linked to
metabolic or reproductive disadvantages spread across
continents, generating a dozen theories suggesting differ-
ent explanations for the evolutionary origin of PCOS (16).
Most these hypotheses prompt a balancing mechanism
between viability selection and metabolic thrift against
fertility disadvantages associated with this condition. For
example, androgenisation and insulin resistancemay con-
fer survival benefit to females and improve the glucose
availability for ovulatory functions in hunter-gatherer so-
cieties (17). Moreover, metabolic thrift and increased fat
storage are advantages for mother and fetus under low
food conditions (18). However, the effect on the individ-
ual fitness of the PCOS phenotype during the evolution of
humans is not understood, andno evolutionary advantage
for the PCOS genotype carriers has been proven. Surpris-
ingly, all previous theories about PCOS consider evolu-
tionary dynamics involving only females, not considering
the contribution of the male in the genotype-phenotype
inheritance and evolution. All the genetic and evolution-
ary analyses of PCOS were carried out on a sample of
female individuals, presumably resulting in biased evalu-
ations and in an overall loss of genetic information.
Genetic markers of the disease
Previous studies identified a hundred candidate genes
associated with PCOS and several genetic markers affect-
ing the pathogenesis, phenotype, and prevalence of the
disease have been proposed (19). Recently, two Genome-
WideAssociation Studies (GWAS) performed inHanChi-
nese women identified 11 new risk loci for PCOS (20, 21),
which count 17 single nucleotide polymorphisms (SNPs)
leading to genetic variants strongly associated with the
disease. The gene sequences located within the PCOS sus-
ceptibility loci are involved in the ovarian response to the
gonadotropic hormones, in themetabolismof glucose and
lipids, and in cell cycle regulation. This finding is corrob-
orated by other studies showing the association between
thesemarkers and the disease (22–27). The results of these
two statistically powerful analyses were confirmed by
otherworks performed in populations of non-Chinese an-
cestry (19, 28, 29), showing a common genetic risk profile
across human populations.
All the genes falling within the susceptibility loci iden-
tified byGWASmay potentially be implicated in themod-
ulation of the PCOS phenotype and its severity. These
genes are FSHR, LHCGR, DENND1A, THADA,
C9orf3, YAP1, HMGA2, RAB5B/SUOX, INSR, TOX3
and SUMO1P1; their potential relation with PCOS was
described separately (Supplemental Discussion).
Geography of PCOS genetic markers
The distribution of the allelic variants associated to
PCOS is different among the populations worldwide, as
observable by Human Genome Diversity Project (HGDP)
selection browser (http://hgdp.uchicago.edu/cgi-bin/gbrowse/
HGDP) (30–32), a web-based software, which calculates
the geographicdistributionsofuser-selectedmarkers from
StanfordSNPgenotypingdata (33, 34).Adifferent genetic
pattern distributionof PCOSmarkers could be reflected in
different phenotypic features of the disease, resulting from
adaptive evolution (19, 28, 35) or from genetic drift gen-
erated by a serial founder effect occurring during the an-
cient human migrations out of Africa (36). Accordingly,
the decay of expected heterozygosity asmeasure of genetic
variation accompanies the increase of genetic and geo-
graphic distance from Africa (33, 34, 37). But the overall
constant prevalence of the disease remains unexplained.
The determination of the genetic background and its
relationship with the phenotype may be relevant to opti-
mize the pharmacological treatment of the disease and
protocols for assisted reproduction. To define the degree
of similarity of the PCOS genotypes, we show a popula-
tion genetics analysis by Bayesian clustering and an eval-
uation of pairwise genetic distance using SNPs data from
different populations, available in online databases. The
genotype-phenotype link and the correlation between ge-
netic and geographic data are discussed from an evolu-
tionary point of view.
Materials and Methods
A detailed description of the methods is available as Supple-
mental Materials and Methods.
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SNP selection
The genetic analyses were performed using the frequencies
data of the 17 PCOS-related SNPs of individuals from human
populations sampled in different world regions. The SNP panel
(Supplemental Materials and Methods) was taken from two
GWAS (20, 21), which found a strong association between
PCOS and the 17 genetic markers. The SNP data were obtained
from the HGDP-CEPH (Centre d’Etude du Polymorphisme Hu-
main) Stanford (33, 34), 1000 Genomes (The 1000 Genomes
Project Consortium, 2010) (38) and in part from the HapMap
(The International HapMap Consortium, 2003) (39) panels,
which provide SNP frequencies and geographical coordinates of
a wide number of human populations worldwide, to ensure a
good coverage in the territorial distribution among the conti-
nents. Based on their geographic coordinates, the populations
were grouped by continent (Supplemental Table 1). All the ge-
netic data are from both male and female individuals unselected
for PCOS, ensuring that the analysis takes into account males as
carrier of a PCOS-linked genotype and avoiding the bias arising
from the use of only PCOS patients.
Selection of PCOS phenotypes
In order to evaluate the link between genotype and ethnicity,
the geographical distribution of the different PCOS phenotypes
was evaluated by analyzing the clinical data registered in the
scientific literature (SupplementalMaterials andMethods). Phe-
notypic data are shown in a world map (Figure 1).
Human genetic clustering analysis
Genetic clustering analysis assigns the individuals to the
group (cluster) that best represents their genetic background,
calculated using the frequencies of PCOS markers. To this end,
SNPsdata from individualswereusedand the genetic population
stratificationwas inferred by the Bayesian analysis implemented
in STRUCTURE 2.3.4 software (Pritchard Lab) (40). The num-
ber of subpopulations (K) inwhich the individualswere assigned
was selected using the Kmethod (41) (Supplemental Figure 1).
The degree of affinity of the populations to the resulting genetic
clusters is expressedas anumeric value (Qvalue) by the software.
Thus, Q values define an estimation of ancestry, inferred by the
SNP frequencies. Then, Q values were grouped for world area,
and used for a graphical representation together with geograph-
ical and clinical data.
The genotype-phenotype linkwas obtained from the analysis
of geographical data and genetic clustering. It was confirmed by
principal component analysis implemented in National Institute
on Aging (NIA) Array Analysis software (42) using the SNP
frequency data.
Evaluation of the genetic drift
To evaluate the contribution of the genetic drift in the estab-
lishment of the modern PCOS markers distribution, a linear re-
gression of the expected/observed heterozygosity and genetic
against geographic distancewasperformed (36). The SNPspanel
was used to obtain the heterozygosity data and to calculate the
Figure 1. World distribution of the affinity to the genetic clusters and PCOS phenotypes prevalence. A, Bar plots of individual Q values calculated
by the STRUCTURE software assign each individual to different subpopulations that matches the main world areas, with a certain degree of
admixture. The analysis was performed differentially for the HGDP and the 1000 Genomes merged together with the HapMap samples. Each color
indicates the membership of individuals in a genetic cluster (K  5); Af, African; CA, Central Asian; ME, Mediterranean/Middle Eastern; Eu,
European; Am, American; Oc, Oceanian. B, Pie chart of cluster affinity among continents, indicating the frequencies of the PCOS susceptibility
markers. The charts were obtained as the means of the Q values by merging the HGDP, 1000 Genomes, and HapMap populations for each
genetic cluster (colors of the pie charts do not refer to panel A). The overall prevalence of a genetic cluster is different between the geographic
area, suggesting a link with the corresponding PCOS phenotype and clinic features, which were obtained by a review of the literature; green,
cluster 1; red, cluster 2; blue, cluster3; yellow, cluster 4; magenta, cluster 5; n.a., data not available or not assessed.
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fixation index (Fst) as ameasure of pairwise genetic distance (43)
resulting by comparing each world population vs Africans. A
scatter plot of Fst and heterozygosity against the geographic dis-
tance was illustrated by the waypoints-method previously de-
scribed (36, 44). Briefly, the geographic distance between pop-
ulations was calculated using Addis Ababa in Ethiopia as the
starting point and taking into account the kilometers covered by
humans during their expansion worldwide through migratory
waypoints. Thewaypointswere chosen simulating themigratory
routes (Supplemental Table 2), assuming that humans bypassed
the natural obstacles duringmigrations, such as oceans and high
mountains. The radius of the Earth was also considered for the
calculation of the geographic distance.
Statistical analysis and image software
ANOVA, t tests, or linear regression analysis was applied as
appropriate and indicated in the figure legends.The statistical anal-
ysis was performed by GraphPad Prism software (GraphPad).
Results
Geographical distribution of PCOS genotypes and
phenotypes
Bayesian genetic clustering analysis assigned the indi-
viduals to five subpopulations (K 5) obtained from the
estimation of the proportion of ancestry inferred by the
SNP frequencies. It can be defined by the Q value as the
degree of affinity of the population to each genetic cluster
by the SNPs combination of the individuals within the
indicated geographic area. Thus, the degree of prevalence
of each cluster is variable among the world continents,
revealing that human populations could be divided into
five groups with geographically different, non-homoge-
neous genetic background calculated using the frequency
of PCOS markers, though a degree of admixture exists
(Figure 1A). The proportion of affinity of the populations
to each genetic cluster is also illustrated for each world
area, which is represented by the prevalent PCOS geno-
type and phenotype (Figures 1B and 2). The metabolic
phenotype characterized by insulin resistance, metabolic
syndrome, type 2 diabetes, hypertension, and acanthosis
nigricans is dominant in Asia, especially Central Asia, and
in America. The hyperandrogenic phenotype predomi-
nates in European, Mediterranean, and Middle Eastern
patients, who show the most severe hirsutism. Consider-
ing African and Oceanian PCOS–affected women, the
phenotype is characterized by both hirsutism and insulin
resistance with a predominant role of the latter feature.
Indeed, a certain degree of mixed PCOS phenotypes co-
Figure 2. Box and whiskers plot of the overall continental membership in each genetic cluster. The continents are represented by the distribution
of the Q values calculated by the STRUCTURE software. The charts, A, were obtained as the means of the Q values by merging the HGDP, 1000
Genomes, and HapMap populations for each genetic cluster. Each cluster is peculiar for a specific geographic area because of the
nonhomogeneous distribution of PCOS susceptibility marker frequencies. The acronym above the bars indicates a significant difference vs Africa,
Af; America, Am; Central Asia, CA; Europe, Eu; East Asia, EA; Middle East/Mediterranean area, ME; and Oceania, Oc. Kruskal-Wallis and Dunn’s
post-test (P  .0001). B, Relationship between genetic background and PCOS phenotype. The genetic clusters are represented by colored ovals
and located in the position of the corresponding phenotype (Figure 1). Prevalence of each cluster in each world area is proportional to the area of
the oval, calculated using Q values; green, cluster 1; red, cluster 2; blue, cluster3; yellow, cluster 4; magenta, cluster 5. C, Clustering by principal
component (PC) analysis performed using SNP genotypes in relation to the metabolic and hyperandrogenic PCOS phenotypes (cumulative
percentage of data set coverage from PC1 and PC2  54.187%). The populations are represented by points colored depending on their
geographical origin (left panel) or prevalent phenotype (right panel).
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exists in each world population, as a result of genetic ad-
mixture (Figure 1).
Genotype-phenotype link
The analysis of the geographical distribution of the
mergedQvalues reveals that the affinity to apredominant,
peculiar genetic cluster is typical for eachcontinent (Figure
2). Thus, the genetic background inferred by PCOSmark-
ers is different and nonhomogeneous among the human
populations fromdiverseworld areas (Figure 2A). Cluster
1 is predominant inAfricans.Cluster 2 is typical inCentral
Asian, European, and Mediterranean/Middle Eastern
people, but with a lesser extent of membership to the clus-
ter 1, revealing that these populations share a similar ge-
netic background, calculated using PCOS markers. How-
ever, Central Asians share a certain degree of membership
also to Cluster 5 together with East Asians. Cluster 3 is
typical of Americans and Eastern Asians. Cluster 4 is typ-
ical of Oceanians and partly of Africans. The degree of
severityof the twomainPCOSphenotypes results fromthe
contribution of the genetic background. Each PCOS ge-
notype is linked to its geographic area with a peculiar
combinationof prevalent PCOS features. This is shownby
clustermemberships, calculated as theQvalue of the prev-
alent clusters in each geographic area (Figure 2B). Indeed,
cluster 1 is well represented in European, Mediterranean/
Middle Eastern, African, andAmerican people, where hy-
perandrogenic hirsutism is mid/severe. Independently of
the PCOS features, cluster 2 is prevalent where the phe-
notype is more severe. Clusters 3 and 5 are represented in
association with the metabolic phenotype, which mainly
differs for the overall severity and type of its features. Af-
rican and Oceanian share a similar phenotype (cluster 4)
characterized by mid degrees of metabolic risk and hy-
perandrogenism, suggesting a genetic similarity for PCOS
markers between these populations, according to the re-
sult of genetic clustering at K  4 (HGDP samples, Sup-
plemental Figure1).The linkbetweenPCOSgenotype and
phenotype was confirmed by principal component anal-
ysis (Figure 2C), given that the population characterized
by the metabolic or hyperandrogenic phenotype shares
peculiar graphareas.However, all clusters are represented
in each geographic area (Figures 1 and 2), probably con-
tributing to the PCOS features and its severity (Figure 2).
Genetic diversity resulting from PCOS markers
The measure of the genetic distance, Fst, calculated for
the panel of PCOS susceptibility markers reveals a strong
diversity in the genetic background among human popu-
lations, grouped by continents (Figure 3). The pairwise Fst
of the non-Africans vsAfricans increases togetherwith the
geographic distance from Africa, producing R2  0.21
Figure 3. Analysis of the genetic distance (Fst) and decay of heterozygosity between continents. The charts were obtained by merging the data
from HGDP, 1000 Genomes, and HapMap populations. A, Scatterplot of heterozygosity and geographic distance. The expected heterozygosity
calculated for PCOS susceptibility loci decreases together with geographic distance, evaluated by linear regression. B, Box and whiskers plot of Fst
distribution grouped for continents. The acronym above the bars indicates a significant difference vs Africa, Af; America, Am; Central Asia, CA;
Europe, Eu; East Asia, EA; Middle East/Mediterranean area, ME; and all other continents, ALL. Kruskal-Wallis and Dunn’s post-test (P  .0001). C,
Scatterplot of Fst and geographic distance calculated using the waypoints. Each point indicates the comparison between African vs other
populations, as specified in the figure legend. Fst calculated for PCOS susceptibility loci increases together with geographic distance, evaluated by
linear regression.
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(P  .0001) calculated by linear regression (Figure 3C)
and indicating the strong contribution of genetic drift in
the establishment of PCOS markers distribution. The de-
cayof the expectedheterozygosity (Figure 3A) strengthens
this observation.The result is corroboratedby the increase
of Fst and decay of heterozygosity, calculated for a wider
range of geneticmarkers in a previous study,when plotted
against the distance from the putative starting point of
human migrations, in Ethiopia (36, 37). Differently from
what expected, the observed heterozygosity does not de-
cay with distance, suggesting a relatively recent genetic
admixture. Moreover, the Fst distributions in Africans vs
other populations (Figure 3A) is different among conti-
nents, indicating strongly diverse, nonhomogeneous allele
frequencies in the distribution of PCOS markers world-
wide (Figure 3).
Discussion
Previous stratification analyses using a wide number of
genetic markers showed that the modern human popula-
tion comprises six main genetic clusters depending on the
ethnic background, reflectingwith surprising accuracy the
ethnicity and admixture degree of ancestry (45). Using the
PCOS markers human population was stratified into five
different genetic clusters falling within two main PCOS
phenotypic groups. Thus, PCOS results in a hyperandro-
genic and in a metabolic phenotype, reflecting the world
distribution of the degree of affinity to genetic clusters.
This analysis provides evidence that PCOS ethnic varia-
tions are stronglydeterminedby thegeneticbackground in
humans (27, 34, 46–48), as already demonstrated by a
comparative experiment between different PCOS mouse
strains (49). Genetic cluster analysis relies on the simul-
taneous combinationofdifferent SNPs, providingahigher
level of accuracy than case-control studies, which, in fact,
yielded conflicting results (50–53), not resulting in any
clear cause-effect indication related to ethnicity and pro-
viding a hundred putativemarkers not independently con-
firmed (19, 51). The study of ethnic variations of PCOS
genotype-phenotype linkmay be a useful approach for the
pharmacological treatment of the disease and during in-
fertility treatment.
PCOS phenotypes
The severity of the PCOS phenotypes may result from
different combinations of SNPs representedby the clusters
(Figure 1 and Figure 2), eg, Americans and Asians with a
prevalence of the metabolic phenotype, belonging to dif-
ferent prevalent clusters (3 and 2, respectively; Figures 1B
and 2). Conversely, European andMediterranean/Middle
Eastern people share the hirsute-hyperandrogenic pheno-
type and a high affinity to cluster 2, but also the affinity to
clusters 1 and 4 is high among populations with a mid
hyperandrogenic phenotype, although characterized by
metabolic features rather thanhirsutism.Thus, theancient
humans’ migratory routes do not completely reflect the
current distribution of the PCOS phenotypes. Additional
considerations regarding the distribution of the genotypes
and phenotypes are available separately (Supplemental
Discussion).
PCOS and genetic diversity among humans
Although other alternatives were proposed and dis-
cussed (54, 55), Fst remains a widely used measure of
genetic distance. The pairwise Fst calculated for the var-
ious populations vs Africans increases together with the
geographic distance from Africa. This result is consistent
with previous data showing that genetic diversity is de-
terminedbya serial founder effect thatoccurredduring the
ancient humanmigrations across the continents (36). The
increase of Fst with the geographic distance calculated for
PCOS markers in humans is the same of that previously
observed for a wider set of genetic markers from different
organisms (36, 56–59), suggesting that its distribution is
the result of the random genetic drift. Nevertheless, the
variations of PCOS phenotypes among continents is dis-
played through various characteristics and symptoms ap-
parently incoherent with the geographic distance (Figure
3), probably as a result of genetic admixture rather than
natural selection. In fact, each world population shares a
different degree of affinity with the five genetic clusters,
and therefore it may differently contribute to phenotype
determination. Limitations due to genetic admixturewere
discussed separately (Supplemental Discussion).
All things considered, the overall continental variabil-
ity of the two main PCOS phenotypes is clearly linked to
a peculiar genetic background, resulting fromgenetic drift
and indicating that different genetic markers may reflect
convergent phenotypic features.
Natural selection or genetic drift?
These data suggest that PCOS genotype and phenotype
may be not strongly affected by natural selection during
human evolution. Nevertheless, the reason why the prev-
alence of PCOS is similar among the different world con-
tinents remains to be demonstrated. A large number of
evolution-based theories were produced and extensively
discussed (16), providing rational evaluations for the evo-
lution of different PCOS phenotypes in females, especially
the metabolic phenotype, but not for the overall constant
prevalence of the disease. Surprisingly, none of these the-
ories considers the male as the carrier of an hyperandro-
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genic trait, which may reasonably provide an improve-
ment of his individual fitness, likely emphasizing the male
secondary sex characteristics. Indeed, both sexes share
most of their genomes and express the same traits, how-
ever resulting in antagonistic selection (60, 61). From this
point of view, the prevalence of PCOS among different
human populations may be the result of the balance be-
tween a positive selection in males against a negative se-
lection in females. Our results are strengthened by the
demonstration that natural selection favors in similar pro-
portions both protective and risk alleles for type 2diabetes
(62), suggesting that the phenotype linked to the disease
results in opposite effects on the fitness of both sexes. Pre-
viousobservations inothermammals support this hypoth-
esis, since the selection for the sex hormone testosterone
leads to antagonistic reproductive fitness between parents
and their opposite-sex progeny (63). On the other hand, it
is well known that evolution is often sex-dependent in
different species (64–67), given that alleles can have pos-
itive effects on fitness in one sex and negative in the other,
resulting in intralocus sexual conflict (61, 68). Different
genetic background for PCOS converging in two main
phenotypes together with overall constant prevalence of
the disease support the presence of intralocus sexual con-
flict, which may have affected the decay of observed
heterozygosity. Even if speculative, in humans this mech-
anism seems to be a “bug” inherited from admixture with
different hominids or from an ancient genome evolved in
environmental and social conditions, strongly different
from those in which Homo sapiens lived in the last
100 000 years (69, 70), but every hypothesis in this regard
must be demonstrated.
Summary
The phenotypic expression of PCOS varies among hu-
man populations, depending on ethnicity. The distribu-
tion of previously identified susceptibility diseasemarkers
results in different, nonhomogeneous continental genetic
backgrounds by Bayesian clustering, reflecting the ethnic
distribution of the main PCOS phenotypes. Thus, a clear
indication for PCOS ethnicity is shown, taking into ac-
count a certain degree of genetic admixture between hu-
man populations. The genetic distance increases together
with the distance fromAfrica, suggesting that the modern
distribution of PCOS susceptibilitymarkers is the result of
genetic drift likely due to a serial founder effect occurred
during the ancient human migrations as alternative to the
natural selection theory. Intralocus sexual conflict may
contribute to themaintenance of an overall constant prev-
alence of PCOS measured in females. The analysis of the
genetic background may lead to important implications
for the pharmacological approach to the disease.
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